See more : Moneta Gold Inc. (MEAUF) Income Statement Analysis – Financial Results
Complete financial analysis of Enfusion, Inc. (ENFN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Enfusion, Inc., a leading company in the Software – Application industry within the Technology sector.
- DeNA Co., Ltd. (DNACF) Income Statement Analysis – Financial Results
- Pepkor Holdings Limited (PPH.JO) Income Statement Analysis – Financial Results
- YCIC Eco-Technology Co.,Ltd. (002200.SZ) Income Statement Analysis – Financial Results
- China National Building Material Company Limited (3323.HK) Income Statement Analysis – Financial Results
- McKesson Europe AG (CAKFY) Income Statement Analysis – Financial Results
Enfusion, Inc. (ENFN)
About Enfusion, Inc.
Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It provides portfolio management system, which generates a real-time investment book of record that consists of valuation and risk tools that allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and order and execution management system that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. The company also offers accounting/general ledger system, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion analytics system, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services. Enfusion Inc. was incorporated in 2021 and is headquartered in Chicago, Illinois.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 174.54M | 150.35M | 111.70M | 79.57M | 59.03M |
| Cost of Revenue | 57.64M | 47.10M | 31.85M | 21.36M | 16.96M |
| Gross Profit | 116.89M | 103.25M | 79.86M | 58.21M | 42.07M |
| Gross Profit Ratio | 66.97% | 68.67% | 71.49% | 73.16% | 71.27% |
| Research & Development | 19.89M | 17.16M | 153.40M | 6.32M | 4.15M |
| General & Administrative | 64.64M | 68.76M | 150.61M | 35.89M | 16.63M |
| Selling & Marketing | 20.42M | 29.29M | 51.73M | 9.93M | 7.43M |
| SG&A | 85.05M | 98.05M | 202.34M | 45.82M | 24.05M |
| Other Expenses | 0.00 | -638.00K | -1.19M | 82.00K | -3.00K |
| Operating Expenses | 104.95M | 115.21M | 355.74M | 52.13M | 28.20M |
| Cost & Expenses | 162.59M | 162.31M | 387.58M | 73.49M | 45.16M |
| Interest Income | 0.00 | 413.00K | 4.59M | 1.66M | 724.00K |
| Interest Expense | 0.00 | 413.00K | 4.59M | 1.66M | 724.00K |
| Depreciation & Amortization | 9.99M | 6.60M | 3.98M | 2.29M | 1.16M |
| EBITDA | 21.94M | -5.62M | -271.91M | 8.37M | 15.02M |
| EBITDA Ratio | 12.57% | -3.74% | -244.49% | 10.62% | 25.45% |
| Operating Income | 11.95M | -11.96M | -275.88M | 6.07M | 13.87M |
| Operating Income Ratio | 6.85% | -7.96% | -246.99% | 7.63% | 23.50% |
| Total Other Income/Expenses | -464.00K | -225.00K | -5.78M | -1.58M | -727.00K |
| Income Before Tax | 11.48M | -12.19M | -281.66M | 4.49M | 13.14M |
| Income Before Tax Ratio | 6.58% | -8.11% | -252.16% | 5.65% | 22.26% |
| Income Tax Expense | 2.23M | 1.07M | 579.00K | 433.00K | 486.00K |
| Net Income | 6.03M | -13.26M | -282.24M | 4.06M | 12.66M |
| Net Income Ratio | 3.45% | -8.82% | -252.68% | 5.10% | 21.44% |
| EPS | 0.10 | -0.16 | -4.30 | 0.04 | 0.11 |
| EPS Diluted | 0.07 | -0.16 | -4.30 | 0.04 | 0.11 |
| Weighted Avg Shares Out | 88.20M | 85.39M | 65.58M | 113.05M | 113.05M |
| Weighted Avg Shares Out (Dil) | 129.43M | 85.39M | 65.58M | 113.05M | 113.05M |
ENFN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Enfusion, Inc. and Encourages Shareholders to Contact the Firm!
Enfusion Inc Investors Urged To Participate In Securities Fraud Investigation Led By The Schall Law Firm
ENFN SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Enfusion, Inc. and Encourages Investors to Contact the Firm
Enfusion Inc Investors Encouraged To Join Securities Fraud Investigation Led By The Schall Law Firm
Enfusion, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - ENFN
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Enfusion, Inc. - ENFN
Shareholder Rights Advocates at Levi & Korsinsky Investigate Enfusion, Inc. (ENFN) Regarding Possible Securities Fraud Violations
ENFN SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Enfusion, Inc. and Encourages Investors to Contact the Firm!
Lost Money on Enfusion, Inc. (ENFN)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
ENFN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Enfusion, Inc. and Encourages Investors to Contact the Firm!
Source: https://incomestatements.info
Category: Stock Reports